Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 1, 2011, Pages 167-174

  Li, Jing ^a   Dabaja, Bouthaina ^a   Reed, Valerie ^a   Allen, Pamela K ^a   Cai, Haihong ^a   Amin, Mayankkumar V ^a   Garcia, John A ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Conformal; Dosimetry; Lymphatic irradiation; Normal tissue toxicity; Radiotherapy

Indexed keywords

CONFORMAL; CORONARY ARTERIES; LEFT ANTERIOR DESCENDING ARTERIES; LYMPHATIC IRRADIATION; MEAN DOSE; MEDIASTINAL MASS; NORMAL STRUCTURE; NORMAL-TISSUE TOXICITY; PHOTON RADIATION; PROTON BEAM THERAPY; RESIDUAL DISEASE;

BIOLOGICAL ORGANS; BLOOD VESSELS; COBALT; DOSIMETRY; HEART; ONCOLOGY; PROTON BEAMS; PROTONS; RADIOTHERAPY; THREE DIMENSIONAL; TISSUE; TOXICITY;

POSITRON EMISSION TOMOGRAPHY;

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; IFOSFAMIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; NAVELBINE; OXALIPLATIN; PARACETAMOL; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COUGHING; DESQUAMATION; DOSIMETRY; DRUG MEGADOSE; DYSPHAGIA; DYSPNEA; ESOPHAGUS; FEMALE; HEART; HOARSENESS; HODGKIN DISEASE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG; MALE; MEDIASTINUM LYMPHOMA; MEDIASTINUM TUMOR; MINIMAL RESIDUAL DISEASE; ODYNOPHAGIA; PHOTON THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DERMATITIS; RADIATION DOSE; THREE DIMENSIONAL PROTON BEAM THERAPY; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR RESISTANCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; CORONARY VESSELS; ESOPHAGUS; FEMALE; HEART; HODGKIN DISEASE; HUMANS; LUNG; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANS AT RISK; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TUMOR BURDEN;

EID: 79961127606     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.007     Document Type: Article

References (34)

1. American Cancer Society Cancer Facts & Figures, 2010 2010 American Cancer Society Atlanta, GA
2. M.J. Adams, S.R. Lipsitz, and S.D. Colan Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy J Clin Oncol 22 2004 3139 3148 (Pubitemid 41103728)
3. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949 1955 (Pubitemid 23312611)
4. J.F. Boivin, G.B. Hutchison, and J.H. Lubin Coronary artery disease mortality in patients treated for Hodgkin's disease Cancer 69 1992 1241 1247
5. M. Belham, A. Kruger, and S. Mepham Monitoring left ventricular function in adults receiving anthracycline-containing chemotherapy Eur J Heart Fail 9 2007 409 414 (Pubitemid 46441967)
6. A.J. Swerdlow, C.D. Higgins, and P. Smith Myocardial infarction mortality risk after treatment for Hodgkin disease A collaborative British cohort study 99 2007 206 214
7. I. Abbes, K. Mrad, and S. Sassi Primary Hodgkin's disease of the nasopharynx: A rare but bona fide disease Pathologica 94 2002 314 316 (Pubitemid 36157411)
8. P.A. Heidenreich, S.L. Hancock, and B.K. Lee Asymptomatic cardiac disease following mediastinal irradiation J Am Coll Cardiol 42 2003 743 749 (Pubitemid 37000197)
9. P.A. Heidenreich, I. Schnittger, and H.W. Strauss Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease J Clin Oncol 25 2007 43 49 (Pubitemid 350003049)
10. M.C. Hull, C.G. Morris, and C.J. Pepine Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy JAMA 290 2003 2831 2837 (Pubitemid 37509491)
11. M.M. Hudson, C.A. Poquette, and J. Lee Increased mortality after successful treatment for Hodgkin's disease J Clin Oncol 16 1998 3592 3600 (Pubitemid 28506773)
12. F.E. van Leeuwen, W.J. Klokman, and A. Hagenbeek Second cancer risk following Hodgkin's disease: A 20-year follow-up study J Clin Oncol 12 1994 312 325 (Pubitemid 24056405)
13. F.E. van Leeuwen, W.J. Klokman, and M.B. Veer Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood J Clin Oncol 18 2000 487 497 (Pubitemid 30078530)
14. M.A. Tucker, C.N. Coleman, and R.S. Cox Risk of second cancers after treatment for Hodgkin's disease N Engl J Med 318 1988 76 81 (Pubitemid 18029298)
15. G.M. Dores, C. Metayer, and R.E. Curtis Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years J Clin Oncol 20 2002 3484 3494
16. S. Acharya, K. Sarafoglou, and M. LaQuaglia Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence Cancer 97 2003 2397 2403 (Pubitemid 36542477)
17. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475 (Pubitemid 37430500)
18. G.M. Chronowski, R.B. Wilder, and S.L. Tucker Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy Int J Radiat Oncol Biol Phys 55 2003 36 43 (Pubitemid 36020342)
19. A.K. Ng, M.P. Bernardo, and E. Weller Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101 2108 (Pubitemid 34408801)
20. D.C. Hodgson, E.S. Koh, and T.H. Tran Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma Cancer 110 2007 2576 2586 (Pubitemid 350174945)
21. E.S. Koh, T.H. Tran, and M. Heydarian A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk Radiat Oncol 2 2007 13
22. S.C. Darby, D.J. Cutter, and M. Boerma Radiation-related heart disease: Current knowledge and future prospects Int J Radiat Oncol Biol Phys 76 2010 656 665
23. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
24. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 Suppl 1 2002 79 83 (Pubitemid 34567406)
25. C.R. Correa, H.I. Litt, and W.T. Hwang Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer J Clin Oncol 25 2007 3031 3037 (Pubitemid 47218049)
26. P.A. Heidenreich, S.L. Hancock, and R.H. Vagelos Diastolic dysfunction after mediastinal irradiation Am Heart J 150 2005 977 982 (Pubitemid 41607777)
27. S.E. Lipshultz, and S.E. Sallan Cardiovascular abnormalities in long-term survivors of childhood malignancy J Clin Oncol 11 1993 1199 1203 (Pubitemid 23199119)
28. E.J. Hall Intensity-modulated radiation therapy, protons, and the risk of second cancers Int J Radiat Oncol Biol Phys 65 2006 1 7
29. H. Paganetti, T. Bortfeld, and T.F. Delaney Neutron dose in proton radiation therapy: In regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7) Int J Radiat Oncol Biol Phys 66 2006 1594-1595
30. U. Schneider, S. Agosteo, and E. Pedroni Secondary neutron dose during proton therapy using spot scanning Int J Radiat Oncol Biol Phys 53 2002 244 251 (Pubitemid 34465830)
31. B. Gottschalk Neutron dose in scattered and scanned proton beams: In regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7) Int J RadiatOncol Biol Phys 66 2006 1594-1594
32. X. Wang, N. Sahoo, and R.X. Zhu Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system Int J Radiat Oncol Biol Phys 76 2010 1562 1570
33. W.D. Newhauser, J.D. Fontenot, and A. Mahajan The risk of developing a second cancer after receiving craniospinal proton irradiation Phys Med Biol 54 2009 2277 2291
34. C. Chung, T. Yock, and J J Proton radiation therapy and the incidence of secondary malignancies Int J Radiat Oncol Biol Phys 69 2007 S178 S179